Genomewide trapping of genes that encode secreted and transmembrane proteins repressed by oncogenic signaling

M Gebauer1, H von Melchner, T Beckers

  • 1ASTA Medica AG, Department of Cancer Research, University of Frankfurt Medical School, Frankfurt am Main, Germany.

Genome Research
|November 3, 2001
PubMed

Insights

This study developed a retroviral gene trap (U3Ceo) to identify genes repressed by oncogenic transformation. It successfully identified genes encoding secreted and transmembrane proteins involved in cancer progression and metastasis.

Area of Science:

  • Genomics
  • Molecular Biology
  • Cancer Research

Background:

  • Oncogenic transformation often involves the repression of specific genes.
  • Identifying these repressed genes can provide insights into cancer mechanisms.
  • Secreted and transmembrane proteins play crucial roles in cellular communication and metastasis.

Purpose of the Study:

  • To develop and utilize a retroviral gene trap (U3Ceo) for genome-wide screening.
  • To identify genes encoding secreted and/or transmembrane proteins repressed by oncogenic transformation.
  • To investigate the role of these genes in oncogenesis and metastatic spread.

Main Methods:

  • Construction of a retroviral gene trap (U3Ceo) with a CD2 cell surface antigen/neomycin-phosphotransferase fusion gene.
  • Screening of a mammalian genome library using insulin-like growth factor 1 (IGF-1) transformation.
  • Selection of neomycin-resistant (Neo(R)) clones expressing the CD2 antigen.
  • Molecular analysis of gene trap integrations to identify disrupted endogenous genes.

Main Results:

  • The U3Ceo gene trap preferentially disrupted genes encoding secreted and transmembrane proteins.
  • Integrations resulted in the fusion of endogenous signal sequences to the reporter gene.
  • Selection against CD2 expression identified integrations in genes repressed by IGF-1 transformation.
  • Analysis revealed captured signal sequences from proteins implicated in oncogenic transformation and metastasis.

Conclusions:

  • The U3Ceo gene trap is effective for identifying genes repressed during oncogenic transformation.
  • This method facilitates the discovery of novel genes involved in cancer progression.
  • The identified genes, particularly those encoding secreted/transmembrane proteins, are potential targets for anti-cancer therapies.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...